Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company that focuses on redefining psychiatric care. Utilizing AI-driven biomarkers, they aim to match patients with the most effective treatments based on their neurobiology. This approach seeks to personalize psychiatric medication, moving away from the traditional trial-and-error method.